Nicola Twilley on the quest for artificial blood. Plus: how the Oscar race got as messy as “Conclave”; the U.S.-Soviet search ...

Health-care companies rose after strong earnings from one obesity-drug maker. Eli Lilly shares rose after it reiterated its forecast for 32% 2025 revenue growth, amid rising demand for its Zepbound ...

A Medical Mystery” and “The Body Transplant” among other novels, radiology professor Heike Daldrup-Link uses storytelling to highlight challenges in healthcare and society.

The drugmaker’s financial forecasts topped Wall Street’s expectations, reassuring investors after it overestimated demand for ...

Although Mounjaro and Zepbound have been headlining Lilly’s financial reports in recent years, the company’s roster of non-incretin products, which grew sales 20% in the fourth quarter, should “help ...

Eli Lilly shares rose Thursday after the drugmaker's adjusted profit came in above estimates, offsetting weaker-than-expected revenue.

Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the ...

Doctors lead patients, they lead treatment teams and support networks. They lead most effectively when they recognize ...

When any part of a lily is ingested, it affects a cat’s kidneys, causing them acute damage. This can lead to kidney failure ...

Trolls criticized Lily Collins for taking part in the 'unethical trend' of surrogacy but her husband has defended their ...

Glaxo Wellcome Distinguished Professor of Medical Journalism Dr. Tom Linden retired last semester, leaving behind a storied ...

On a quiet summer evening in June 1990, Pico Iyer sat in his family home in Santa Barbara, California, when suddenly, he was surrounded by walls of flames five stories ...